NCT01815125View on ClinicalTrials.gov

Ondansetron for Pediatric Mild Traumatic Brain Injury

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Traumatic Brain InjuryBrain Concussion
Interventions
DRUG

Ondansetron

The intervention of interest will be the administration of one dose of oral ondansetron in the emergency department. The dosage will be 8 mg.

DRUG

PLacebo

placebo

Trial Locations (1)

H3T1C5

CHU Sainte-Justine, Montreal

All Listed Sponsors
lead

St. Justine's Hospital

OTHER

NCT01815125 - Ondansetron for Pediatric Mild Traumatic Brain Injury | Biotech Hunter | Biotech Hunter